- 专利标题： DIACYLGLYERCOL KINASE MODULATING COMPOUNDS
-
申请号： US17845534申请日： 2022-06-21
-
公开(公告)号： US20230060354A1公开(公告)日： 2023-03-02
- 发明人: Julian A. Codelli , Michael Graupe , Juan A. Guerrero , Stephen D. Holmbo , Tetsuya Kobayashi , Yasamin Moazami , Leena B. Patel , Heath A. Weaver , Jie Xu , Suet C. Yeung , QingMing Zhu
- 申请人： Gilead Sciences, Inc.
- 申请人地址： US CA Foster City
- 专利权人： Gilead Sciences, Inc.
- 当前专利权人： Gilead Sciences, Inc.
- 当前专利权人地址： US CA Foster City
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D519/00
摘要：
The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.
公开/授权文献
- US11976072B2 Diacylglycerol kinase modulating compounds 公开/授权日：2024-05-07
信息查询
